France Single-Use Bioreactors Market (2026-2031)
The France Single-Use Bioreactors Market was valued at $113.4 Million in 2026 and projected to reach to $192.5 Million by 2031, representing a compound annual growth rate of 11.2%. France's single-use bioreactors market is poised for sustained expansion through 2031, supported by the country's strong biopharmaceutical sector and increasing preference for disposable technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France Single-Use Bioreactors Market Trends and Insights
- France is capitalizing on the global shift toward disposable bioreactor technologies, driven by increasing demand for flexible, cost-effective bioprocessing solutions in pharmaceutical and biopharmaceutical manufacturing.
- The French market benefits from strong regulatory frameworks, advanced healthcare infrastructure, and a growing number of contract manufacturing organizations (CMOs) adopting single-use systems. The 11.2% compound annual growth rate (CAGR) reflects France's strategic position within Europe's biotech ecosystem.
- France's investment in cell and gene therapy development, coupled with rising production volumes for monoclonal antibodies and recombinant proteins, is accelerating adoption of single-use bioreactors across the country.
- Key drivers include reduced capital expenditure, faster time-to-market, and enhanced operational flexibility that French manufacturers increasingly prioritize.
- By 2031, France is expected to solidify its role as a leading European hub for single-use bioprocessing innovation and deployment..
Key Market Statistics
- CAGR (2026-2031) 11.2% CAGR
- Market Size, 2026 ~USD 113.4 Million
- Forecast, 2031 ~USD 192.5 Million
- Country France
France Single-Use Bioreactors Market Overview
Strong Market Valuation :
France's single-use bioreactors market reached USD 113.4 million in 2026, demonstrating significant adoption of disposable bioprocessing technologies across the country's pharmaceutical sector.
Robust Growth Trajectory :
With an 11.2% CAGR, France's market is expanding faster than many European counterparts, driven by increased investment in biopharmaceutical manufacturing and contract manufacturing organizations (CMOs).
Projected Market Expansion :
The French market is forecasted to reach USD 192.5 million by 2031, representing a 69.6% increase over the five-year period, reflecting sustained demand for flexible bioprocessing solutions.
Regulatory and Infrastructure Support :
France's established pharmaceutical regulatory framework and advanced manufacturing infrastructure position the country as a key hub for single-use bioreactor adoption in Europe.
France Single-Use Bioreactors Market Dynamics
- French manufacturers and CMOs are increasingly adopting single-use systems to enhance operational flexibility, reduce contamination risks, and lower capital expenditure.
- The shift toward personalized medicine and cell therapy production further accelerates demand for scalable, cost-effective bioprocessing solutions. Government initiatives promoting biotech innovation and the presence of major pharmaceutical companies in France create favorable conditions for market growth.
- Investment in manufacturing capacity and technological advancement will drive adoption across small-scale research facilities and large-scale commercial production.
- By 2031, single-use bioreactors are expected to become the preferred choice for French biopharmaceutical manufacturers seeking competitive advantages in global markets..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- France's single-use bioreactors market is valued at USD 113.4 million in 2026 and will reach USD 192.5 million by 2031, representing an 11.2% CAGR.
- France's strong biotech ecosystem and CMO expansion are driving rapid adoption of single-use bioreactor technologies across the country.
- Cell and gene therapy development in France is a primary growth catalyst, alongside increased monoclonal antibody and recombinant protein production.
- France's regulatory environment and healthcare infrastructure position it as a key European leader in single-use bioprocessing innovation through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
France Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : French and international pharma companies operating in France need market data to optimize bioprocessing investments, evaluate single-use technology adoption, and plan manufacturing capacity expansion.
- Contract Manufacturing Organizations (CMOs) : French CMOs require detailed market insights to assess demand for single-use bioreactor services, benchmark pricing strategies, and identify growth opportunities in the expanding French biotech sector.
- Equipment and Technology Suppliers : Bioreactor manufacturers and bioprocessing technology providers need France-specific market data to develop localized sales strategies, identify customer segments, and forecast revenue potential.
- Private Equity and Investment Firms : Investors evaluating opportunities in French biotech and pharmaceutical manufacturing require market sizing and growth projections to assess investment returns and portfolio company valuations.
- Government and Policy Makers : French regulatory bodies and economic development agencies use market intelligence to inform biotech policy, funding initiatives, and infrastructure development supporting the biopharmaceutical industry.
Reasons to Buy this Report
- Country-Specific Market Sizing : Obtain precise valuation data for France's single-use bioreactors market (USD 113.4M in 2026, USD 192.5M in 2031) to benchmark investments and competitive positioning within the French market.
- Growth Rate Intelligence : Understand France's 11.2% CAGR trajectory compared to the global 12% benchmark, enabling strategic planning for market entry, expansion, or partnership decisions in the French biopharmaceutical sector.
- Regulatory and Infrastructure Insights : Gain actionable intelligence on France's pharmaceutical regulatory environment, manufacturing capabilities, and infrastructure supporting single-use bioreactor adoption for compliant market operations.
- Competitive Landscape Analysis : Identify key French manufacturers, CMOs, and technology providers driving market growth, enabling targeted partnership and acquisition strategies within the French bioprocessing ecosystem.
- Investment and Expansion Planning : Leverage France-specific market forecasts and growth drivers to develop data-backed business cases for manufacturing facility investments, R&D initiatives, and market penetration strategies.
Frequently asked questions
What is the current market size of single-use bioreactors in France?
France's single-use bioreactors market was valued at USD 113.4 million in 2026 and is projected to grow to USD 192.5 million by 2031.
What is the expected growth rate for France's single-use bioreactors market?
France's single-use bioreactors market is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2031.
What are the primary drivers of growth in France's single-use bioreactors market?
Key growth drivers in France include increased cell and gene therapy development, rising monoclonal antibody production, reduced capital expenditure requirements, faster time-to-market, and expanding contract manufacturing operations adopting single-use technologies.
Which sectors in France are adopting single-use bioreactors most rapidly?
France's pharmaceutical and biopharmaceutical manufacturing sectors, particularly contract manufacturing organizations (CMOs) and companies focused on cell and gene therapies, are leading the adoption of single-use bioreactor systems.
How does France's market compare to the broader European single-use bioreactors market?
France represents a significant portion of Europe's single-use bioreactors market, driven by its advanced healthcare infrastructure, strong regulatory framework, and robust biotech ecosystem that supports innovation and manufacturing excellence.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
